Dec 9, 2013
Posted by Seb in categories: biotech/medical, environmental, nanotechnology
Tim Parker, Benzinga Staff Writer
Before scientists create something that has mainstream uses, it often starts as science fiction.
A new deep within IBM’s (NYSE: IBM [FREE Stock Trend Analysis]) Singapore research facility isn’t quite ready for the mainstream but when it is, the implications for those who suffer from fungal infections and later, other infections, could have a new ally in their fight but this ally is completely different than current treatments.
If you’re a fan of Star Trek, you’ve seen nanotechnology. These are microscopic machines that get inside machines or in this case, the body, to identify and fix problems.